RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/2C0261FB2815E09A8F5F405496246962BA384F823F271AD9A6C9DDFE26B1A88B19D79C3B1EF9DB0DD95FC10952A41467http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/2C0261FB2815E09A8F5F405496246962BA384F823F271AD9A6C9DDFE26B1A88B19D79C3B1EF9DB0DD95FC10952A41467http://www.w3.org/2000/01/rdf-schema#comment"The aim of this work was to explore the conformational characteristics of rat/mouse MOG35-55 immunodominant epitope. The results are discussed in terms of rational design of altered peptide ligands or non-peptide mimetics based on rat MOG35-55 that could be served as potential inhibitors of experimental autoimmune encephalomyelitis"xsd:string
http://purl.uniprot.org/uniprot/#_832F0DCE91EC989B233F1EADFADD7AA825FE369AE279D183B9250B550357470BFB1C2F26DA1294C0EAFBDF8FE421FEFChttp://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/2C0261FB2815E09A8F5F405496246962BA384F823F271AD9A6C9DDFE26B1A88B19D79C3B1EF9DB0DD95FC10952A41467
http://purl.uniprot.org/uniprot/Q3UY21http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/2C0261FB2815E09A8F5F405496246962BA384F823F271AD9A6C9DDFE26B1A88B19D79C3B1EF9DB0DD95FC10952A41467
http://purl.uniprot.org/uniprot/#_Q3UY21-mappedCitation-27483998http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/2C0261FB2815E09A8F5F405496246962BA384F823F271AD9A6C9DDFE26B1A88B19D79C3B1EF9DB0DD95FC10952A41467